Literature DB >> 25698543

Mouse models of glioma.

Stanley S Stylli1, Rodney B Luwor2, Thomas M B Ware2, Fiona Tan2, Andrew H Kaye3.   

Abstract

Gliomas are the most common primary tumour in the central nervous system in adults. The pathological hallmark of gliomas is their propensity for extensive infiltration into the surrounding brain parenchyma which results in tumour recurrence. Despite the use of optimal surgical removal and adjuvant therapies the most aggressive of these tumours, glioblastoma multiforme, has a poor patient prognosis, with median survival of less than 15 months. In this review, we discuss mouse glioma models that have been utilised to advance our basic knowledge of the processes involved in gliomagenesis and their use in the testing of novel therapies and treatment regimens in the preclinical setting.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain tumour; Glioma; Mouse model; Therapy

Mesh:

Year:  2015        PMID: 25698543     DOI: 10.1016/j.jocn.2014.10.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  32 in total

1.  Growth pattern of experimental glioblastoma.

Authors:  Jonatan Ahlstedt; Karolina Förnvik; Gunther Helms; Leif G Salford; Crister Ceberg; Gunnar Skagerberg; Henrietta Nittby Redebrandt
Journal:  Histol Histopathol       Date:  2020-02-05       Impact factor: 2.303

2.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

3.  Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation.

Authors:  Elena Biasibetti; Alberto Valazza; Maria T Capucchio; Laura Annovazzi; Luigi Battaglia; Daniela Chirio; Marina Gallarate; Marta Mellai; Elisabetta Muntoni; Elena Peira; Chiara Riganti; Davide Schiffer; Pierpaolo Panciani; Michele Lanotte
Journal:  Comp Med       Date:  2017-03-01       Impact factor: 0.982

Review 4.  Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies.

Authors:  Mohammad Salemizadeh Parizi; Fatemeh Salemizadeh Parizi; Saeed Abdolhosseini; Shohreh Vanaei; Ali Manzouri; Farnoosh Ebrahimzadeh
Journal:  Inflammopharmacology       Date:  2021-10-06       Impact factor: 4.473

Review 5.  Assessing drug response in engineered brain microenvironments.

Authors:  Kinsley M Tate; Jennifer M Munson
Journal:  Brain Res Bull       Date:  2019-05-01       Impact factor: 4.077

6.  Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

Authors:  Fernando Francisco Borges Resende; Simoneide Souza Titze-de-Almeida; Ricardo Titze-de-Almeida
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

Review 7.  Stem Cell Pathology.

Authors:  Dah-Jiun Fu; Andrew D Miller; Teresa L Southard; Andrea Flesken-Nikitin; Lora H Ellenson; Alexander Yu Nikitin
Journal:  Annu Rev Pathol       Date:  2017-10-20       Impact factor: 23.472

Review 8.  Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas.

Authors:  Pranjali P Kanvinde; Adarsha P Malla; Nina P Connolly; Frank Szulzewsky; Pavlos Anastasiadis; Heather M Ames; Anthony J Kim; Jeffrey A Winkles; Eric C Holland; Graeme F Woodworth
Journal:  Glia       Date:  2021-02-27       Impact factor: 7.452

9.  BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair.

Authors:  Shaolu Zhang; Xin Peng; Xiaofei Li; Hongyan Liu; Baoquan Zhao; Moshe Elkabets; Yao Liu; Wei Wang; Ran Wang; Yuxu Zhong; Dexin Kong
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

Review 10.  Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.

Authors:  Maria B Garcia-Fabiani; Santiago Haase; Andrea Comba; Stephen Carney; Brandon McClellan; Kaushik Banerjee; Mahmoud S Alghamri; Faisal Syed; Padma Kadiyala; Felipe J Nunez; Marianela Candolfi; Antonela Asad; Nazareno Gonzalez; Marisa E Aikins; Anna Schwendeman; James J Moon; Pedro R Lowenstein; Maria G Castro
Journal:  Front Oncol       Date:  2021-06-08       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.